Study of ARO-HBV in Normal Adult Volunteers and Patients With Hepatitis B Virus (HBV)

    Not Recruiting
  • participants needed
  • sponsor
    Arrowhead Pharmaceuticals
Updated on 22 June 2021
James Hamilton, MD
Primary Contact
Queen Mary Hospital (4.4 mi away) Contact
+6 other location
hepatitis b antigen


The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of single- and multiple-ascending doses of ARO-HBV in healthy adult volunteers and participants with hepatitis B virus (HBV).

Condition Hepatitis B
Treatment Sterile Normal Saline (0.9% NaCl), ARO-HBV Injection
Clinical Study IdentifierNCT03365947
SponsorArrowhead Pharmaceuticals
Last Modified on22 June 2021

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note